Cite
HARVARD Citation
Inagaki, N. et al. (n.d.). Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, 12‐week study1. Diabetes, obesity & metabolism. 15 (12), pp. 1136-1145. [Online].